Also trades as: 4547.T (JPX) · $vol 2M
KSPHF OTC
Kissei Pharmaceutical Co., Ltd.
1W: -2.4%
1M: -4.9%
3M: -4.9%
YTD: -9.2%
1Y: -19.1%
3Y: +35.8%
5Y: +25.6%
$24.50
-1.27 (-4.93%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$276.8B
+13.4% ▲
5Y CAGR: +157.8%
Total Liabilities
$43.8B
+29.1% ▲
5Y CAGR: +150.7%
Shareholders Equity
$231.6B
+10.8% ▲
5Y CAGR: +1.1%
Cash & Investments
$54.8B
+12.6% ▲
5Y CAGR: +4.3%
Total Debt
$1.3B
-1.7% ▼
5Y CAGR: -6.3%
Net Debt
-$28.0B
-17.1% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $247M | $368M | $22.9B | $25.2B | $29.2B |
| Short-Term Investments | $23.1B | $23.7B | $23.0B | $23.5B | $25.5B |
| Cash & ST Investments | $53.2B | $49.6B | $45.9B | $48.7B | $54.8B |
| Net Receivables | $22.8B | $22.8B | $28.7B | $29.7B | $31.8B |
| Inventory | $19.0B | $22.8B | $26.3B | $25.0B | $25.7B |
| Other Current Assets | $4.4B | $5.5B | $3.6B | $3.7B | $3.5B |
| Total Current Assets | $99.3B | $100.6B | $104.6B | $107.0B | $115.7B |
| Property, Plant & Equip. | $198M | $185M | $24.9B | $27.1B | $28.3B |
| Goodwill & Intangibles | $1.6B | $1.5B | $2.0B | $1.9B | $2.0B |
| Long-Term Investments | $794M | $563M | $128.9B | $107.5B | $104.9B |
| Other Non-Current Assets | -$1.4B | -$1.4B | $610M | $2M | $25.4B |
| Total Non-Current Assets | $1.1B | $907M | $156.4B | $137.1B | $161.1B |
| Total Assets | $2.0B | $1.7B | $260.9B | $244.1B | $276.8B |
| — Liabilities — | |||||
| Accounts Payable | $4.1B | $4.6B | $4.9B | $4.6B | $6.7B |
| Short-Term Debt | $1.6B | $1.5B | $1.3B | $1.3B | $1.3B |
| Deferred Revenue | $22M | $14M | $0 | $0 | $851M |
| Other Current Liabilities | $7.8B | $6.7B | $9.1B | $9.2B | $5.7B |
| Total Current Liabilities | $18.7B | $15.0B | $17.7B | $16.6B | $21.8B |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $10M | $8M | $940M | $875M | $837M |
| Total Non-Current Liabilities | $143M | $86M | $22.1B | $17.4B | $22.0B |
| Total Liabilities | $297M | $199M | $39.8B | $33.9B | $43.8B |
| — Equity — | |||||
| Common Stock | $24.4B | $24.4B | $24.4B | $24.4B | $24.5B |
| Retained Earnings | $118.2B | $125.6B | $127.3B | $131.5B | $137.1B |
| Accumulated OCI | $47.5B | $32.7B | $0 | $0 | $61.2B |
| Total Stockholders Equity | $201.4B | $193.9B | $220.0B | $209.0B | $231.6B |
| Total Liabilities & Equity | $2.0B | $1.7B | $260.9B | $244.1B | $276.8B |
| — Key Metrics — | |||||
| Total Debt | $1.6B | $1.5B | $1.3B | $1.3B | $1.3B |
| Net Debt | -$230M | -$353M | -$21.6B | -$23.9B | -$28.0B |
| Total Investments | $23.9B | $24.3B | $151.9B | $131.0B | $130.5B |